RespireRx Pharmaceuticals Inc (RSPI)

[katano]

Out stock is offered to investor for 0.001 and the investor will raze &200.000 just by shorting the actual price share and covering after the note will be delivered...

The ("COMMITMENT NOTE" worth $25.000), understand the screwing language...


On July 28, 2020, RespireRx Pharmaceuticals, Inc. (the “Company”) entered into an equity purchase agreement (the “EPA”) and a registration rights agreement (the “Registration Rights Agreement”) with White Lion Capital, LLC (the “Investor”) pursuant to which the Investor agreed to invest up to $2,000,000 to purchase the Company’s common stock, par value $0.001 (“Common Stock”) at a purchase price of 85% of the lowest daily volume weighted average price of the Common Stock for the five trading days prior to a given Closing Date, as defined in the EPA. Additionally, the Company issued to the Investor a convertible note (the “Commitment Note”) with a face amount of $25,000.